In summary, our studies have shown that Cas9-mediated heterozygous RPS19 mutations in healthy donor CD34+ HSPCs cause DBA-like erythroid defects and a TP53-dependent deficiency in bone marrow repopulation after xenotransplantation. This evidence concerns the gene CD34 and Diamond-Blackfan anemia.